Objective: To assess cumulative patient dose and to calculate associated radiation risks for patients undergoing abdominal endovascular aortic aneurysm repair (EVAR).
Introduction

X
-ray imaging for image guided treatment, preoperative planning and postoperative surveillance is frequently used in vascular surgery.
It is well known that X-ray imaging is associated with a certain risk for induction of malignant lesions, particularly if the radiation dose becomes relatively high. Proper radiation protection is required for such practices. Justification and optimization of practices are the two main principles in radiation protection. Specific guidance for proper radiation protection in medical applications is provided in a publication of the International Commission on Radiological Protection (ICRP) 'Radiological Protection In Medicine' 1 . Justification of radiation exposure for patients undergoing abdominal endovascular aortic aneurysm repair (EVAR) implies that EVAR, and its associated preoperative planning and postoperative surveillance, should as a rule improve patient care and that radiation induced side effects are minimized. In other words, radiation exposure for patients undergoing EVAR should do more good than harm to the individual patient. Optimization implies that the level of radiation protection is the best achievable under the prevailing circumstances, maximizing the margin of benefit over radiation induced harm.
Pre-and peroperative radiation exposure for patients undergoing EVAR is already relatively high and may accumulate further during postoperative surveillance depending on the type and frequency of postoperative testing, particularly when complications occur which are endovascularly treated. This raised concern about radiation doses and particularly about the potential radiation induced carcinogenic effect in the long term 2 .
The x-ray imaging modalities that are used for patients undergoing EVAR are radiography, fluoroscopy and computed tomography (CT). For these imaging techniques, assessment of radiation exposure of patients is rather straightforward, and can be based on the output of x-ray imaging equipment. An adequate measure of the output is generally provided on the operator console after the examination, either as a dose-area product (fluoroscopy, radiography) or computed tomography dose index (CT scanner). Radiation risk assessment is required for balancing benefits against harm. In addition to the late mortality risk resulting from exposure to ionizing radiation, other acute and late mortality risks have to be taken into account for proper risk assessment of the complete EVAR procedure. These include the procedure related mortality risk and risks of death from aneurysm, other cardiovascular and non-vascular causes 3 .
In this study two imaging strategies for EVAR were taken as a starting point, one strategy corresponding with traditional practices (traditional protocol) and one with more recent practices (reduced dose protocol). The associated radiation exposures was assessed for both practices.
Next, comprehensive radiation risk assessment was performed taking into account mortality rates that are typical for the EVAR population. To achieve this, a demographic methodology based on life tables was developed. These data were used to quantify the cumulative patient radiation dose and associated mortality risk for patients after abdominal endovascular aortic aneurysm repair (EVAR) in relation to all cause mortality risk for these patients.
Methods
Clinical practice
A traditional protocol for x-ray imaging of patients undergoing EVAR was defined based on a guideline of the European Collaborators on Stent-graft Techniques for Abdominal Aortic Aneurysm Repair (EUROSTAR) protocol 4;5 . A reduced dose protocol was derived from observed clinical practices. Surveillance with duplex ultrasound may be performed in EVAR patients but was not considered in this study since it does not add to the radiation exposure and radiation risk evaluation.
Radiation exposure
Radiation exposure from pre-operative and peroperative angiography depends strongly on the used equipment, local practices, experience of the operator and complexity of the procedure.
For this study the exposure was estimated as 10 mSv effective dose per procedure 6 . Organ doses resulting from fluoroscopy corresponding to an effective dose of 10 mSv were assessed using PCXMC Monte Carlo software (STUK, Radiation and Nuclear Safety Authority, Finland).
Assessment of radiation exposure from CT scans, i.e. organ doses and effective dose, was estimated from the clinical CT acquisition protocols as implemented in one hospital (ImPACT CT Patient Dose Calculator; 7 ). Radiation exposure resulting from four radiographs of the abdomen was calculated from measurements of the dose area product using an anthropomorphic phantom representing a standard adult (Rando Male Phantom, The Phantom Laboratory, Salem, NY, USA) followed by organ dose and effective dose calculations with PCXMC Monte Carlo software. Doses were assessed for organs for which information on age and gender dependent excess relative radiation risk is provided in BEIR VII 8 , i.e. bone marrow, stomach, colon, liver, lung, breast, prostate, uterus, ovary, bladder, thyroid, and finally, as one group, all other organs.
Risk assessment
Risk assessment was performed for males and females at four clinically relevant ages, i.e. patients undergoing abdominal EVAR at the ages of 55, 65, 75 and 85 years old; the age of 75 is approximately the average age of patients treated for abdominal aortic aneurysms 9 . The BEIR VII excess relative risk (ERR) model was used for radiation risk assessment 8 . In the BEIR VII model, organ specific solid cancer mortality is expressed relative to the background risk of solid tumor mortality; taking into account both gender and age. Data on the background risk of solid tumor mortality depending on organ, gender and attained age were derived from ICRP Publication 103 (Euro-American cancer mortality rates by age and site) 10 . Next, according to the BEIR VII model, an overall ERR function depending on organ dose, gender, age at exposure, and attained age was calculated for male and female patients with EVAR at the ages of 55, 65, 75 and 85 years old. Incurred organ dose was also incorporated in the risk model as a function of attained age, this was required because patients who undergo EVAR are exposed at different ages. In addition to radiation risk, mortality rates that are typical for the EVAR population were taken into account, i.e. the probability of 30-day mortality (0.007 at the ages 55 and 65; 0.016 at the age of 75; and 0.022 at the age of 85) and the mortality rate from AAA-related causes in general during follow-up (6 per 15 000 patient months) 3 .
Life tables are used in demography for measuring and modeling population processes and they allow for calculation of death rate, life expectancy and reduction of life expectancy. The radiation induced, age, gender, and dose dependent overall mortality for the European population (Eurostat database 11 ), was incorporated in life tables together with EVAR related mortality rates that are typical for the patient population and the gender and age specific probability of dying.
Results
Clinical practices
Traditional clinical practice included one pre-operative contrast enhanced CT scan in the arterial phase and a pre-operative angiogram, followed by fluoroscopy guided EVAR. Post operative evaluation after EVAR was performed directly after the procedure, and followed by surveillance 1, 3, 6, 12, 18, 24, and 36 months after EVAR; after 36 months surveillance was performed yearly.
Common clinical practice is currently associated with reduced application of medical imaging, it includes one pre-operative contrast enhanced CT scan in the arterial phase, followed by fluoroscopy guided EVAR. Post operative evaluation after EVAR is performed directly after the procedure, and followed by yearly surveillance. The post operative evaluation and surveillance sessions included radiography (four projections (AP, LAT, 30°LPO, 30°RPO)) and CT (two contrast enhanced scans, one arterial phase and one delayed phase scan).
Radiation exposure
Radiation exposure per procedure is presented in Table 1 . Organ doses and effective dose are listed for pre-operative CT, pre-operative fluoroscopy, operative fluoroscopy, post operative and surveillance CT, and post operative and surveillance abdominal radiographs. Relatively high organ doses were assessed for bone marrow, stomach, colon, liver, uterus, ovaries, and bladder. From the radiation exposure per procedure and the observed practices, appropriate organ doses and effective dose were assigned to the year before EVAR; to the year in which EVAR was performed, and the years of post operative evaluation and surveillance (Table 2) .
Due to the intensive use of x-ray imaging the effective dose accumulates rapidly to hundreds of millisieverts for patients treated with EVAR; this is illustrated in Figure 1 by the cumulative effective dose. 
Risk assessment
Demographic and risk related parameters were derived from the life tables for patients aged 55, 65, 75 and 85 years at EVAR. This information is presented in Table 3 . The number of natural deaths (per 1000 EVAR patients) increases with increasing age. The reason is that at higher ages the overall (natural) mortality increases rapidly, and both radiation induced deaths and AAA related deaths decrease with increasing age; this decrease is more prominent for radiation induced deaths. The number of radiation induced deaths is much smaller than the number of AAA related deaths.
The reduction of life expectancy associated with radiation exposure was for the traditional and 6 . Under these latter conditions, the cumulative effective dose would be 115 mSv over a 10-year period. It is well known that considerable inter-hospital variations occur in radiation exposure for patients in both diagnostic-and interventional radiology. This is well illustrated by the large difference in the above reported median effective dose for EVAR, respectively 27 mSv and 8.7 mSv, whereas the reported fluoroscopy time is about the same. Reasons for such differences in patient dose may be technical (configuration and commissioning of the x-ray equipment), or operator dependent (choice for a certain fluoroscopy mode, proper use of collimation, positioning of the detector). The effective dose of 27 mSv seems to be rather high. In our calculations we used an estimated effective dose for fluoroscopy of 10 mSv. The patient dose of 16 mSv for computed tomography used in our calculations is close to the reported value of 13 mSv 2 , and substantially higher compared to the value of 5.4 mSv reported by Geijer et al. 6 . Thus, patient dose from CT resulting from the EVAR surveillance regimen that was assumed for this study may be relatively high but is certainly well within the range of doses that occur in clinical practice.
We did not consider additional image guided interventions in our dose calculations. The number and intensity of these interventions varies to a great degree and can therefore not be standardized. With additional procedures the cumulative dose will rise accordingly, adding to the risk of radiation induced mortality.
Epidemiological and experimental studies provide evidence of radiation induced cancer risk, albeit with uncertainties at doses of about 100 mSv or less 10 . This suggests that radiation risks should be taken seriously, particularly for EVAR patients for whom cumulative effective dose during intensive surveillance protocols may exceed 100 mSv considerably. It has been recommended that epidemiologic studies should be performed on cohorts of patients that receive repeated CT scans during follow-up studies 8 . Results from such epidemiologic studies on patient cohorts are not yet available. Therefore, methodologies for assessing the potential risks associated with high-dose radiological examination based on effective dose and generic fatal cancer estimates are proposed as a crude estimate of the number of fatal cancers 12 .
Knowledge on radiation induced cancer risk is mainly derived from studies on radiation carcinogenesis at low doses in the atomic bomb survivors in Japan. Such a methodology was for example applied for estimating the risk of cancer from diagnostic X-ray imaging for the UK and 14 other countries 13 . Inevitably, inaccuracies of such methodologies occur due to the well known uncertainties in current quantitative radiation risk estimates. A major source of uncertainty and a fundamental shortcoming of such approaches is that specific demographic characteristics of patient cohorts are neglected. Published risk estimates are commonly based on the assumption that radiation induced carcinogenesis in patients is equal to that in the general population. Such an approach is inappropriate, particularly in EVAR patients, since EVAR procedure related risks and an increased risk of death from aneurysm, other cardiovascular and non-vascular causes, strongly determine life expectancy and the probability to develop a fatal (late) radiation induced cancer. Radiation carcinogenesis is a late effect that will be less prominent if additional competing mortality risks are taken into account. This study shows that radiation risk estimates can be calculated taking into account other relevant mortality risks.
This was achieved by the application of life tables that integrate mortality from natural causes, radiation induced cancers, and EVAR and health status related mortality risks.
The probability of long term survival of patients after EVAR, stratified according to age, was reported in a study by Schermerhorn et al. For the 67-74 year age interval the 48 month probability of survival after EVAR was 0.78; for the 75-84 year age interval the probability was 0.69; and for the ≥85 year age interval the probability was 0.52 9 . For the demographic model used in this study the 48 month probability of survival after EVAR was 0.95 for patients undergoing EVAR at the age of 55; and 0.92, 0.68 and 0.56 for patients undergoing EVAR at the age of 65, 75
an 85 years, respectively. Although comparison of the published data for the age intervals cannot be compared straightforwardly to the age specific results of this study, we concluded that the demographic model compares well with the observed survival of patients that underwent EVAR.
The results of this study show that a methodology based on life tables and a well accepted model for radiation carcinogenesis can be used to calculate radiation induced deaths and an associated radiation induced reduction of life expectancy for patients that undergo EVAR. The calculations show that for patients that are prone to exposure to a high cumulative effective dose, the risk of radiation induced carcinogenesis still remains rather small, both in quantitative terms as well as compared to procedure and health status related mortality risks. For a typical 75 year old EVAR patient, the number of radiation induced deaths per 1000 EVAR patients is 4 (3), whereas the procedure and AAA related deaths is 67 (67) per 1000 EVAR patients. Corresponding average radiation induced reduction of life expectancy is 8 (5) days, and procedure and AAA related reduction of life expectancy is 197 (197) days (figures corresponding respectively to the traditional and reduced dose (between brackets) protocol). It is concluded that cumulative radiation exposure in EVAR patients, although relatively high, should not be associated with a major concern with regard to radiation carcinogenesis. Still, any opportunity for optimization and reduction of radiation exposure of EVAR patients should of course be pursued.
The two main study limitations are inaccuracies in BEIR VII model for radiation risk assessment and uncertainties in patient dose assessment. Inherent inaccuracies of the BEIR VII committee's preferred ERR model for estimating site-specific solid cancer mortality are the estimated errors for the fit parameters for the model; and the uncertainty of the most appropriate dose and dose-rate reduction factor (DDREF). Uncertainties in patient dose assessment originate from the well know phenomenon of large variations in patient dose for one and the same procedure; and from the lack of reliable information on typical exposures for patients undergoing EVAR. However in this study we choose commonly accepted values, both with regard to the ERR, DDREF and organ doses. Furthermore the effect that was observed was large enough to reliably conclude that radiation risks associated with EVAR are modest and much smaller compared to AAA related risks.
Although radiation risks are of minor concern in EVAR patients, there are still good reasons for reconsidering current practices. First, it is a legal and ethical requirement that exposure to radiation is always kept as low as possible, secondly the increasing number of EVAR patients that now undergo intensive follow up place a growing burden on imaging capacity (equipment, radiologists) and associated financial resources. Considering the increase of radiation associated mortality risk with the decrease of age at EVAR procedure, the urge for reduction of radiation exposure is especially strong for endovascular procedures in younger patients, for instance after traumatic vascular injury. The most promising option for dose reduction and health care cost saving in the EVAR population is optimization of the surveillance protocols.
Recent practices already indicate less frequent application of x-ray imaging. Other suggested changes in EVAR surveillance are the use of color duplex ultrasonography 14 ; introduction of roentgen stereophotogrammetric analysis which provides (compared to CT) lower dose and more cost effective surveillance 15 ; and introduction of a reduced surveillance regimen 16 .
Therefore further efforts are still needed to achieve optimized surveillance of patients that underwent EVAR but it should be taken into account that optimization of surveillance should also take into account detection of nonaneurysmal-related findings, particularly with CT 17 .
Conclusion
Based on the results of this study, we conclude that radiation exposure accumulates rapidly for patients undergoing abdominal EVAR. However, associated radiation risks are modest and much smaller compared to AAA related risks.
